Signal active
Investment Firm
Overview
SWK Holdings Corporation (“SWK”) is a publicly traded, specialized finance company with a focus on the global healthcare sector. SWK partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for both SWK’s business partners and its investors.
Highlights
1996
Financial Services
11-50
12
11
8
N/A
Private Equity Firm
Location
Dallas, Texas, United States, North America
Contact Information
Social
Profile Resume
SWK Holdings, established in 1996 and headquartered in United States, North America., specializes in investments across Biotechnology, Health Care, Pharmaceutical, Clinical Trials, Manufacturing, Therapeutics, Medical Device, Hospital, Venture Capital, Medical. The organization boasts a portfolio of 12 investments, with an average round size of $19.1M and 8 successful exits. Their recent investments include Parnell Living Science, Journey Medical, Shield Therapeutics, MedMinder Systems, Accelmed. The highest investment round they participated in was $3.3B. Among their most notable exits are Parnell Living Science and Journey Medical. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
12
0
11
8
Investments
12
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Aug 30, 2022 | MedMinder Systems | Health Care | 25.0M |
Dec 15, 2022 | - | - | 4.0M |
Sep 28, 2023 | Shield Therapeutics | Biotechnology | 20.0M |
Jan 02, 2024 | Journey Medical | Pharmaceutical | 20.0M |
Exits
8
Funding Timeline
12
3
0
Funding Rounds
12
SWK Holdings has raised 12 rounds. Their latest funding was raised on Jan 02, 2024 from a Post-IPO Debt - Journey Medical round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Aug 30, 2022 | Debt Financing - MedMinder Systems | - | 25.0M | - |
Dec 15, 2022 | Post-IPO Debt - Elutia | - | 4.0M | - |
Sep 28, 2023 | Post-IPO Debt - Shield Therapeutics | - | 20.0M | - |
Jan 02, 2024 | Post-IPO Debt - Journey Medical | - | 20.0M | - |
Investors
6
SWK Holdings is funded by 6 investor(s). First Horizon Bank and First Horizon Bank Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Debt - SWK Holdings | 30.0M |
- | Yes | Post-IPO Debt - SWK Holdings | 15.0M |
First Horizon Bank | Yes | Post-IPO Debt - SWK Holdings | 15.0M |
- | No | Post-IPO Debt - SWK Holdings | 3.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Jul 08, 2024
thefly.com - SWK Holdings names Adam C. Rice as new CFO
News
May 18, 2024
Investing.com - Earnings call: SWK Holdings focuses on life science finance growth
News
Apr 11, 2024
Seeking Alpha - SWK Holdings Offers Attractive 9% Baby Bond (NASDAQ:SWKH)
News
Mar 25, 2024
Tipranks - SWK Holdings' Enteris Assets Option Deal with AptarGroup - TipRanks.com
News
Mar 25, 2024
Yahoo Finance - SWK Holdings Corp (SWKH) Earnings: A Mixed Bag with Revenue Uptick and Net Income Dip
News
Feb 05, 2024
MarketWatch - SWK Holdings Finance Chief Heinrichson to Resign